Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXG18D
|
||||
| Drug Name |
6-(3-(furan-2-yl)benzylamino)-9-(3-hydroxypropyl)-9H-purine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL497235
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H18N6O2
|
||||
| Canonical SMILES |
OCCCn1cnc2c(NCc3cccc(c3)c4occc4)nc(nc12)C#N
|
||||
| InChI |
InChI=1S/C20H18N6O2/c21-11-17-24-19(18-20(25-17)26(13-23-18)7-3-8-27)22-12-14-4-1-5-15(10-14)16-6-2-9-28-16/h1-2,4-6,9-10,13,27H,3,7-8,12H2,(H,22,24,25)
|
||||
| InChIKey |
JZEFKJPYPCBZGF-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.